amifostine anhydrous has been researched along with Cystitis in 4 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Cystitis: Inflammation of the URINARY BLADDER, either from bacterial or non-bacterial causes. Cystitis is usually associated with painful urination (dysuria), increased frequency, urgency, and suprapubic pain.
Excerpt | Relevance | Reference |
---|---|---|
"Ifosfamide (IFS) is an antineoplastic alkylating agent whose major side effect is hemorrhagic cystitis (HC)." | 7.74 | Amifostine and glutathione prevent ifosfamide- and acrolein-induced hemorrhagic cystitis. ( Batista, CK; Brito, GA; Cunha, FQ; Leitão, BT; Mota, JM; Ribeiro, RA; Souza, MH; Souza, ML, 2007) |
"Ifosfamide (IFS) is an antineoplastic alkylating agent whose major side effect is hemorrhagic cystitis (HC)." | 3.74 | Amifostine and glutathione prevent ifosfamide- and acrolein-induced hemorrhagic cystitis. ( Batista, CK; Brito, GA; Cunha, FQ; Leitão, BT; Mota, JM; Ribeiro, RA; Souza, MH; Souza, ML, 2007) |
"radiotherapy plus amifostine for cancer treatment." | 2.43 | Amifostine reduces side effects and improves complete response rate during radiotherapy: results of a meta-analysis. ( Clark, LG; Clark, OA; Sasse, AD; Sasse, EC, 2006) |
"Colitis was seen significantly lower in the radiation + gemcitabine + amifostine group (P = 0." | 1.35 | The role of amifostine on late normal tissue damage induced by pelvic radiotherapy with concomitant gemcitabine: an in vivo study. ( Altug, T; Atalar, B; Dinçbaş, FO; Gedik, N; Ilvan, S; Koca, S; Oksüz, DC; Ozel, S, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dinçbaş, FO | 1 |
Oksüz, DC | 1 |
Atalar, B | 1 |
Altug, T | 1 |
Ilvan, S | 1 |
Gedik, N | 1 |
Ozel, S | 1 |
Koca, S | 1 |
Sasse, AD | 1 |
Clark, LG | 1 |
Sasse, EC | 1 |
Clark, OA | 1 |
Batista, CK | 1 |
Mota, JM | 1 |
Souza, ML | 1 |
Leitão, BT | 1 |
Souza, MH | 1 |
Brito, GA | 1 |
Cunha, FQ | 1 |
Ribeiro, RA | 1 |
Srivastava, A | 1 |
Nair, SC | 1 |
Srivastava, VM | 1 |
Balamurugan, AN | 1 |
Jeyaseelan, L | 1 |
Chandy, M | 1 |
Gunasekaran, S | 1 |
1 review available for amifostine anhydrous and Cystitis
Article | Year |
---|---|
Amifostine reduces side effects and improves complete response rate during radiotherapy: results of a meta-analysis.
Topics: Amifostine; Cystitis; Deglutition Disorders; Esophagitis; Humans; Neoplasms; Radiation Injuries; Rad | 2006 |
3 other studies available for amifostine anhydrous and Cystitis
Article | Year |
---|---|
The role of amifostine on late normal tissue damage induced by pelvic radiotherapy with concomitant gemcitabine: an in vivo study.
Topics: Amifostine; Animals; Colitis; Collagen; Combined Modality Therapy; Cystitis; Deoxycytidine; Fibrosis | 2009 |
Amifostine and glutathione prevent ifosfamide- and acrolein-induced hemorrhagic cystitis.
Topics: Acrolein; Amifostine; Animals; Antidotes; Antineoplastic Agents, Alkylating; Cystitis; Dose-Response | 2007 |
Evaluation of uroprotective efficacy of amifostine against cyclophosphamide induced hemorrhagic cystitis.
Topics: Amifostine; Animals; Carcinogens; Cyclophosphamide; Cystitis; Hemorrhage; Radiation-Protective Agent | 1999 |